Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
98,294,118
-
Total 13F shares
-
24,444,347
-
Share change
-
+24,218,632
-
Total reported value
-
$1,127,544,026
-
Price per share
-
$46.34
-
Number of holders
-
61
-
Value change
-
+$1,117,084,030
-
Number of buys
-
59
Institutional Holders of ARS Pharmaceuticals, Inc. - Common Stock (SPRY) as of Q4 2020
As of 31 Dec 2020,
ARS Pharmaceuticals, Inc. - Common Stock (SPRY) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,444,347 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, EcoR1 Capital, LLC, RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, Nantahala Capital Management, LLC, Cormorant Asset Management, LP, AMERIPRISE FINANCIAL INC, BlackRock Inc., and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
61
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.